Beneficial Effects of Natural Products on Management of Xerostomia
Beneficial Effects of Specific Natural Products on Management of Xerostomia: A Randomized Controlled Clinical Trial
1 other identifier
interventional
28
1 country
1
Brief Summary
Xerostomia, the subjective feeling of oral dryness, is a symptom most frequently accompanied by either decreased salivary flow or an altered composition of saliva. Hyposalivation, on the other hand, is the objective measured reduction in salivary flow rate. Xerostomia is a relatively common complaint, particularly among older people, and can lead to major consequences with regard to the quality of their general and oral health and wellbeing. Xerostomia has a variety of possible etiological factors; it is generally classified as having primary and secondary causes. Primary causes comprise conditions that directly affect the salivary glands and induce xerostomia like, Sjogren's syndrome, diabetes mellitus type 1 and 2, thyroid disease, adrenal pathology, renal or hepatic diseases, hepatitis C virus infection, and HIV disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 2, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedMay 9, 2024
May 1, 2024
1 month
January 2, 2024
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in subjective dry mouth score
subjective dry mouth scores were calculated as the number of asked questions about dry mouth symptoms (0-4), and patients with a score higher than 1 considered having xerostomia so higher scores more than 1 out of 4 indicating xerostomia but lower scores suggesting improvement.
one month
Secondary Outcomes (3)
Changes in objective dry mouth score
one month
Salivary flow rates
one month
Salivary Nitric oxide levels
one month
Study Arms (2)
(Manuka honey-green tea) interventional arm
ACTIVE COMPARATOR• (Manuka honey-green tea) will topically be applied to the oral mucosa as oral rinse 3 times per day to treat xerostomia.
Saline mouthwash control group
PLACEBO COMPARATORPatients in the control arm followed the same protocol with normal saline rinses in the same bottles 3 times per day for xerostomia
Interventions
Manuka honey is a natural honey, and green tea are herbs Dried green tea leaves (100 gm) will be soaked into 500 ml of methanol solution for two days. Green tea plus ginger mouthwash was prepared by adding 50% green tea extract and 50% ginger extract. After extraction, the extract was filtered and taker to the vacuum evaporator to remove the solvent. The mouthwash was prepared by adding 3 gm of each extract, 0.12 gm sodium saccharin, and one liter distilled water, then every 20 ml of Manuka honey were added in 100 ml of (green tea and ginger solution). Finally, the mixture was stirred vigorously until all the particles were dissolved. Thereafter the obtained mixture was filtered. The mouthwash then filled in sterilized amber color bottles of 250 ml each. According to similar studies performed in this field, the patients used a 20ml of (Manuka honey-green tea- ginger) mouthwash three times a day (preferably after their meals), kept it for one minute, and then poured it out
Eligibility Criteria
You may qualify if:
- \- Both genders, aged above 19 years.
- All patients must have complaint of xerostomia.
- Objective dry mouth score from (2-5).
- Subjective dry mouth score from (1-4).
- Patients must be able to make reliable decision or communications.
You may not qualify if:
- \- Smoking, Alcohol.
- Patient with history of any serious illness as malignancy.
- Patients with any autoimmune disease.
- Vulnerable groups such as pregnant females, prisoners, mentally and physically handicapped individuals.
- Known hypersensitivity or severe adverse effects to the treatment drugs or to any ingredient of their preparation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The British University in Egypt
Cairo, 3753450, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will not know the intervention in each group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2024
First Posted
January 22, 2024
Study Start
August 1, 2022
Primary Completion
September 1, 2022
Study Completion
October 1, 2022
Last Updated
May 9, 2024
Record last verified: 2024-05